EIB, European Commission and VaxThera boost Latin America’s vaccine capacity by up to 250 million doses a year
The European Investment Bank (EIB), in partnership with the European Commission, is providing a €15 million venture loan to VaxThera, a Colombian biotechnology company developing, manufacturing and commercialising vaccines and biopharmaceutical products. The deal is being announced in New York on the margins of the 81st session of the United Nations General Assembly. This is the first tranche of an approved €35 million financing package. The financing will support the construction, fitting out and validation of the second phase of the company’s commercial-scale facility for producing vaccines and biological medicines. It will also fund technology transfer and research and development activities addressing areas of high unmet medical need.
Plus de European Investment Bank — Press releases
- Dalla BEI, con InvestEU e SACE, un finanziamento da 80 milioni di euro al Gruppo FNM per lo sviluppo della mobilità a idrogeno
- El BEI y Banca March firman un acuerdo de garantías para facilitar hasta 280 millones de euros de financiación a pymes y midcaps españolas
- University in central Ukrainian city of Poltava reopens building for thousands of students after EU-backed renovation
La suite de ce fil est réservée aux abonnés
Chaque communiqué de cette source dès sa parution — plus de 80 autres fils, recherches enregistrées et alertes instantanées.
7 jours, sans carte bancaire.
Lisez les communiqués comme celui-ci dès leur parution.
1,400+ flux — en direct sur PPN World en ce moment. Chaque communiqué de cette source dès sa parution — plus de 80 autres fils, recherches enregistrées et alertes instantanées.
Commencer l'essai gratuit →Votre annonce ensuite ? Diffusez votre communiqué sur les fils mondiaux avec PPN Source — et suivez sa reprise ici, en direct.
PPN Source →